Drug Profile
Ketotifen fumarate ophthalmic - Novartis Ophthalmics
Alternative Names: Zaditen; Zaditor; ZatidenLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Novartis Ophthalmics
- Class Antiallergics; Eye disorder therapies; Piperidines; Sedating antihistamines; Small molecules; Thiophenes
- Mechanism of Action Histamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Allergic conjunctivitis
Most Recent Events
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 18 Oct 2004 Launched as a 0.05% formulation for Allergic conjunctivitis in Japan (Ophthalmic)
- 19 Mar 2003 Data presented at the 60th Anniversary Meeting of the American Academy of Allergy and Asthma and Immunology (AAAAI-2003) have been added to the Asthma therapeutic trials section